Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
作者信息
Rayman G, Lumb A N, Kennon B, Cottrell C, Nagi D, Page E, Voigt D, Courtney H C, Atkins H, Higgins K, Platts J, Dhatariya K, Patel M, Newland-Jones P, Narendran P, Kar P, Burr O, Thomas S, Stewart R
机构信息
The Ipswich Diabetes Centre, East Suffolk and North Essex NHS Foundation Trust, Colchester.
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford.
出版信息
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
Abstract
摘要
相似文献
1
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes.
Diabet Med. 2021 Jan;38(1):e14378. doi: 10.1111/dme.14378. Epub 2020 Sep 21.
2
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
Diabetes Metab Res Rev. 2021 Feb;37(2):e3379. doi: 10.1002/dmrr.3379. Epub 2020 Jul 20.
3
COVID-19 and dexamethasone-induced hyperglycaemia: Workload implications for diabetes inpatient teams.
Diabet Med. 2022 Feb;39(2):e14716. doi: 10.1111/dme.14716. Epub 2021 Oct 22.
4
COVID-19 and diabetes mellitus. Importance of glycemic control.
Clin Investig Arterioscler. 2021 May-Jun;33(3):148-150. doi: 10.1016/j.arteri.2021.05.001.
5
Effect of COVID 19 pneumonia on hyperglycemia: Is it different from non COVID pneumonia?
Diabetes Metab Syndr. 2022 Feb;16(2):102407. doi: 10.1016/j.dsx.2022.102407. Epub 2022 Jan 19.
6
Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
Diabetes Care. 2020 Jul;43(7):1427-1432. doi: 10.2337/dc20-0941. Epub 2020 May 14.
7
An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
Diabet Med. 2021 Mar;38(3):e14509. doi: 10.1111/dme.14509. Epub 2021 Feb 5.
8
One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.
J Diabetes Investig. 2022 Jan;13(1):19-21. doi: 10.1111/jdi.13644. Epub 2021 Sep 1.
9
Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4007-e4016. doi: 10.1210/clinem/dgab409.
10
Does glycemic control affect outcome of COVID-19?
J Diabetes. 2020 Dec;12(12):868-869. doi: 10.1111/1753-0407.13116. Epub 2020 Oct 3.
引用本文的文献
1
COVID-19 management in patients with comorbid conditions.
World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674.
2
Impact of diabetes on COVID-19 and glucocorticoids on patients with COVID-19 and diabetes during the Omicron variant epidemic: a multicenter retrospective cohort study in South China.
BMC Infect Dis. 2024 Jul 18;24(1):706. doi: 10.1186/s12879-024-09287-z.
3
Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone.
Endocrine. 2024 Nov;86(2):556-563. doi: 10.1007/s12020-024-03841-0. Epub 2024 May 31.
4
Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus.
World J Diabetes. 2024 Apr 15;15(4):606-622. doi: 10.4239/wjd.v15.i4.606.
5
Tipped Over the Edge: A Case of Diabetes Ketoacidosis Precipitated by High-Dose Steroids in the Setting of a Large Peritonsillar Abscess.
Cureus. 2024 Mar 25;16(3):e56917. doi: 10.7759/cureus.56917. eCollection 2024 Mar.
6
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem.
Endocrinol Metab (Seoul). 2024 Apr;39(2):222-238. doi: 10.3803/EnM.2024.1951. Epub 2024 Mar 27.
7
Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study.
SAGE Open Med. 2024 Mar 20;12:20503121241238148. doi: 10.1177/20503121241238148. eCollection 2024.
8
[Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jan 20;55(1):230-235. doi: 10.12182/20240160602.
9
Diabetes Mellitus, Energy Metabolism, and COVID-19.
Endocr Rev. 2024 Mar 4;45(2):281-308. doi: 10.1210/endrev/bnad032.
10
Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19.
Pharmaceuticals (Basel). 2023 Sep 13;16(9):1290. doi: 10.3390/ph16091290.
本文引用的文献
1
New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic.
Diabet Med. 2020 Jul;37(7):1210-1213. doi: 10.1111/dme.14327. Epub 2020 Jun 8.
2
Practical recommendations for the management of diabetes in patients with COVID-19.
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23.
3
Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group.
Diabet Med. 2018 Aug;35(8):1011-1017. doi: 10.1111/dme.13675.
4
Maintaining glycaemic control during high-dose prednisolone administration for hyperemesis gravidarum in Type 1 diabetes.
Diabet Med. 2004 Mar;21(3):298-9. doi: 10.1046/j.1464-5491.2003.01026_21_3.x-i1.
Zotero 插件